Tenaya Therapeutics Inc Total Liabilities

Latest as of September 2025: $22.11 Million USD

Tenaya Therapeutics Inc total liabilities. Based on the latest financial reports, Tenaya Therapeutics Inc (TNYA) has total liabilities worth $22.11 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Tenaya Therapeutics Inc to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Tenaya Therapeutics Inc (2019–2024)

Total liabilities of Tenaya Therapeutics Inc from 2019 to 2024. This chart illustrates how Tenaya Therapeutics Inc's total liabilities have evolved over time, based on quarterly financial data. Explore TNYA strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Tenaya Therapeutics Inc Competitors by Total Liabilities

The table below lists competitors of Tenaya Therapeutics Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Qua Granite Hayal Yapi ve Urunleri Sanayi Ticaret AS IS:QUAGR	Turkey	TL10.51 Billion
Jetway Information Co Ltd TWO:6161	Taiwan	NT$458.01 Million
Jasa Armada Indonesia Tbk PT JK:IPCM	Indonesia	Rp384.48 Billion
JLK Inc KQ:322510	Korea	₩34.80 Billion
Morn Sun Feed Mill Corp TWO:1240	Taiwan	NT$753.54 Million
Tacheng Real Estate Co Ltd TWO:6171	Taiwan	NT$1.79 Billion
Kuyas Yatirim AS IS:KUYAS	Turkey	TL164.29 Million
Muhibbah Engineering M Bhd KLSE:5703	Malaysia	RM1.61 Billion

Liability Composition Analysis (2019–2024)

This chart breaks down Tenaya Therapeutics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Tenaya Therapeutics Inc assets under control.

Liquidity & Leverage Metrics

Tenaya Therapeutics Inc Total Liabilities Ratios Explained

Tenaya Therapeutics Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	4.64	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.27	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.21	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Tenaya Therapeutics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Tenaya Therapeutics Inc (2019–2024)

The table below shows the annual total liabilities of Tenaya Therapeutics Inc from 2019 to 2024.

Year	Total Liabilities	Change
2024-12-31	$27.09 Million	-12.88%
2023-12-31	$31.09 Million	-12.59%
2022-12-31	$35.57 Million	-6.69%
2021-12-31	$38.12 Million	+337.07%
2020-12-31	$8.72 Million	-89.33%
2019-12-31	$81.74 Million	--

About Tenaya Therapeutics Inc

NASDAQ:TNYA USA Biotechnology

Market Cap

$78.01 Million

Market Cap Rank

#19979 Global

#4578 in USA

Share Price

$0.36

Change (1 day)

-0.19%

52-Week Range

$0.36 - $1.54

All Time High

$29.58